Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Multi-drug Injection in Total Knee Arthroplasty
NCT02299349Completed
- Sponsor
- TriHealth
- Start
- Aug 2013
- Primary completion
- Dec 2013
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by TriHealth. Primary endpoint: Visual Analog Pain at 1 day. Started Aug 2013; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02299349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299349.